Lucid Diagnostics Inc. (LUCD) Form 10-K Annual Reports
Lucid Diagnostics Inc. (LUCD) is a publicly traded company on the Nasdaq, categorized under SIC 3841 (Surgical & Medical Instruments & Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LUCD
CIK: 1799011
Exchange: Nasdaq
SIC 3841: Surgical & Medical Instruments & Apparatus
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerJin Dong
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-16 | 2026-10-12 | 8-K | 0001493152-26-047404 | View SEC Doc Filr Page |
| 8-K | 2026-09-22 | 2026-09-22 | 8-K | 0001493152-26-043659 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001493152-26-037596 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | FORM 10-Q | 0001437749-26-027335 | View SEC Doc Filr Page |
| 8-K | 2026-06-24 | 2026-06-24 | 8-K | 0001493152-26-029943 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-20 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001094891-26-000217 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001493152-26-022877 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | FORM 10-Q | 0001437749-26-016751 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-30 | — | DEFA14A | 0001493152-26-020716 | View SEC Doc Filr Page |
| ARS | 2026-04-30 | 2025-12-31 | ARS | 0001493152-26-020711 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-30 | 2026-04-30 | DEF 14A | 0001493152-26-020708 | View SEC Doc Filr Page |
| 3/A | 2026-04-24 | 2026-03-23 | AMENDED INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001094891-26-000204 | View SEC Doc Filr Page |
| 8-K | 2026-04-24 | 2026-04-24 | 8-K | 0001493152-26-018926 | View SEC Doc Filr Page |
| 424B5 | 2026-04-23 | — | 424B5 | 0001493152-26-018791 | View SEC Doc Filr Page |
| 8-K | 2026-04-23 | 2026-04-23 | 8-K | 0001493152-26-018725 | View SEC Doc Filr Page |
| PRE 14A | 2026-04-20 | 2026-04-20 | PRE 14A | 0001493152-26-018123 | View SEC Doc Filr Page |
| 3 | 2026-04-13 | 2026-03-23 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001094891-26-000189 | View SEC Doc Filr Page |
| S-8 | 2026-04-03 | — | S-8 | 0001493152-26-014996 | View SEC Doc Filr Page |
| S-8 | 2026-04-03 | — | S-8 | 0001493152-26-014995 | View SEC Doc Filr Page |
| EFFECT | 2026-03-26 | — | EFFECT Filing | 9999999995-26-000944 | View SEC Doc Filr Page |
| 424B5 | 2026-03-26 | — | 424B5 | 0001493152-26-012968 | View SEC Doc Filr Page |
| 8-K | 2026-03-26 | 2026-03-26 | 8-K | 0001493152-26-012807 | View SEC Doc Filr Page |
| S-3/A | 2026-03-26 | — | S-3/A | 0001493152-26-012729 | View SEC Doc Filr Page |
| CORRESP | 2026-03-25 | — | CORRESP Filing | 0001493152-26-012730 | View SEC Doc Filr Page |
| 10-K | 2026-03-25 | 2025-12-31 | FORM 10-K | 0001437749-26-009805 | View SEC Doc Filr Page |